Multifocal infantile hemangioma with extracutenous involvement Advocacy Hub | UniteRare

At a Glance

Live from database

Regulatory Watchboard

1 event

Jun 2017

Gleolan: FDA approved

Optical imaging agent indicated in patients with glioma (suspected World Health Organization Grades III or IV on preoperative imaging) as an adjunct for the visualization of malignant tissue during surgery

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Patient Assistance Programs1

Gleolan

NX Development Corporation

OpenContact for details

View all support programs on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Multifocal infantile hemangioma with extracutenous involvement.
Search all trials →

Search clinical trials for Multifocal infantile hemangioma with extracutenous involvement →

Recent News & Research

No recent news articles indexed yet for Multifocal infantile hemangioma with extracutenous involvement.
Search PubMed for Multifocal infantile hemangioma with extracutenous involvement →

Browse all Multifocal infantile hemangioma with extracutenous involvement news →

Specialist Network

No specialists currently listed for Multifocal infantile hemangioma with extracutenous involvement.

View all Multifocal infantile hemangioma with extracutenous involvement specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰